In 2023, Biotest completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Biotest has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Biotest amounted to 33,765 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2020, the total operational greenhouse gas (GHG) emissions of Biotest increased by 24.42%, suggesting that the company faced challenges in reducing its emissions from its core operations.
In 2023, the total Scope 1 emissions of Biotest were 18,301 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Compared to the previous year (2020), Biotest's Scope 1 emissions decreased by 1.47%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.
In 2023, Biotest reported Scope 2 greenhouse gas (GHG) emissions of 15,464 tCOâ‚‚e without specifying the calculation method.
Compared to the previous year (2020), Biotest's Scope 2 emissions (Unspecified Calculation Method) rose by 80.58% in 2023, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy
In 2023, Biotest reported its Scope 2 emissions using an unspecified methodology.